SMA Europe

Latest News

06/02/2020

Risdiplam shown to improve motor function in people aged 2 to 25 with type 2 or 3 SMA

14/01/2020

Roche announces global pre-approval access/ compassionate use (PAA/CU) plans for risdiplam

26/12/2019

AVXS-101 (Zolgensma®) to be made available globally through a controversial programme

Latest Projects